CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Open-market buy Chief Operating & Legal Office bought 13,725 shares at $2.91 ($39,940)
- 4 Open-market buy President & CEO bought 7,172 shares at $2.28 ($16,352)
- 4 Open-market buy President & CEO bought 237,941 shares at an average $2.25 ($534,743)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
Page 3 of 62 · 1,225 filings